Global Gene Modifying Immunotherapy for Blood Cancer Market Size, Status and Forecast 2024-2031

Report ID: 934729 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 CAR T-cell Therapy
        1.2.3 TCR T-cell Therapy
    1.3 Market by Application
        1.3.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Acute Lymphocytic Leukemia
        1.3.3 Chronic Lymphocytic Leukemia
        1.3.4 B Cell Lymphoma
        1.3.5 Multiple Myeloma
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Perspective (2016-2027)
    2.2 Gene Modifying Immunotherapy for Blood Cancer Growth Trends by Regions
        2.2.1 Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Gene Modifying Immunotherapy for Blood Cancer Historic Market Share by Regions (2016-2021)
        2.2.3 Gene Modifying Immunotherapy for Blood Cancer Forecasted Market Size by Regions (2022-2027)
    2.3 Gene Modifying Immunotherapy for Blood Cancer Industry Dynamic
        2.3.1 Gene Modifying Immunotherapy for Blood Cancer Market Trends
        2.3.2 Gene Modifying Immunotherapy for Blood Cancer Market Drivers
        2.3.3 Gene Modifying Immunotherapy for Blood Cancer Market Challenges
        2.3.4 Gene Modifying Immunotherapy for Blood Cancer Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Gene Modifying Immunotherapy for Blood Cancer Players by Revenue
        3.1.1 Global Top Gene Modifying Immunotherapy for Blood Cancer Players by Revenue (2016-2021)
        3.1.2 Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Players (2016-2021)
    3.2 Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Gene Modifying Immunotherapy for Blood Cancer Revenue
    3.4 Global Gene Modifying Immunotherapy for Blood Cancer Market Concentration Ratio
        3.4.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Modifying Immunotherapy for Blood Cancer Revenue in 2020
    3.5 Gene Modifying Immunotherapy for Blood Cancer Key Players Head office and Area Served
    3.6 Key Players Gene Modifying Immunotherapy for Blood Cancer Product Solution and Service
    3.7 Date of Enter into Gene Modifying Immunotherapy for Blood Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Modifying Immunotherapy for Blood Cancer Breakdown Data by Type
    4.1 Global Gene Modifying Immunotherapy for Blood Cancer Historic Market Size by Type (2016-2021)
    4.2 Global Gene Modifying Immunotherapy for Blood Cancer Forecasted Market Size by Type (2022-2027)

5 Gene Modifying Immunotherapy for Blood Cancer Breakdown Data by Application
    5.1 Global Gene Modifying Immunotherapy for Blood Cancer Historic Market Size by Application (2016-2021)
    5.2 Global Gene Modifying Immunotherapy for Blood Cancer Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Gene Modifying Immunotherapy for Blood Cancer Market Size (2016-2027)
    6.2 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
        6.2.1 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021)
        6.2.2 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2022-2027)
        6.2.3 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2027)
    6.3 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
        6.3.1 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2021)
        6.3.2 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2022-2027)
        6.3.3 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2027)
    6.4 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Country
        6.4.1 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2016-2021)
        6.4.2 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size (2016-2027)
    7.2 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
        7.2.1 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021)
        7.2.2 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2022-2027)
        7.2.3 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2027)
    7.3 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
        7.3.1 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2021)
        7.3.2 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2022-2027)
        7.3.3 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2027)
    7.4 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Country
        7.4.1 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2016-2021)
        7.4.2 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size (2016-2027)
    8.2 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
        8.2.1 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2027)
    8.3 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
        8.3.1 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2027)
    8.4 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Region
        8.4.1 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size (2016-2027)
    9.2 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
        9.2.1 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021)
        9.2.2 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2022-2027)
        9.2.3 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2027)
    9.3 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
        9.3.1 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2021)
        9.3.2 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2022-2027)
        9.3.3 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2027)
    9.4 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Country
        9.4.1 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2016-2021)
        9.4.2 Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size (2016-2027)
    10.2 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
        10.2.1 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2027)
    10.3 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
        10.3.1 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2027)
    10.4 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Country
        10.4.1 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Details
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Gene Modifying Immunotherapy for Blood Cancer Introduction
        11.1.4 Novartis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
        11.1.5 Novartis Recent Development
    11.2 Kite Pharma
        11.2.1 Kite Pharma Company Details
        11.2.2 Kite Pharma Business Overview
        11.2.3 Kite Pharma Gene Modifying Immunotherapy for Blood Cancer Introduction
        11.2.4 Kite Pharma Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
        11.2.5 Kite Pharma Recent Development
    11.3 Juno Therapeutics
        11.3.1 Juno Therapeutics Company Details
        11.3.2 Juno Therapeutics Business Overview
        11.3.3 Juno Therapeutics Gene Modifying Immunotherapy for Blood Cancer Introduction
        11.3.4 Juno Therapeutics Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
        11.3.5 Juno Therapeutics Recent Development
    11.4 Cellectis
        11.4.1 Cellectis Company Details
        11.4.2 Cellectis Business Overview
        11.4.3 Cellectis Gene Modifying Immunotherapy for Blood Cancer Introduction
        11.4.4 Cellectis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
        11.4.5 Cellectis Recent Development
    11.5 Ziopharm Oncology
        11.5.1 Ziopharm Oncology Company Details
        11.5.2 Ziopharm Oncology Business Overview
        11.5.3 Ziopharm Oncology Gene Modifying Immunotherapy for Blood Cancer Introduction
        11.5.4 Ziopharm Oncology Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
        11.5.5 Ziopharm Oncology Recent Development
    11.6 Celyad
        11.6.1 Celyad Company Details
        11.6.2 Celyad Business Overview
        11.6.3 Celyad Gene Modifying Immunotherapy for Blood Cancer Introduction
        11.6.4 Celyad Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
        11.6.5 Celyad Recent Development
    11.7 Bluebird Bio
        11.7.1 Bluebird Bio Company Details
        11.7.2 Bluebird Bio Business Overview
        11.7.3 Bluebird Bio Gene Modifying Immunotherapy for Blood Cancer Introduction
        11.7.4 Bluebird Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
        11.7.5 Bluebird Bio Recent Development
    11.8 Bellicum Pharmaceuticals
        11.8.1 Bellicum Pharmaceuticals Company Details
        11.8.2 Bellicum Pharmaceuticals Business Overview
        11.8.3 Bellicum Pharmaceuticals Gene Modifying Immunotherapy for Blood Cancer Introduction
        11.8.4 Bellicum Pharmaceuticals Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
        11.8.5 Bellicum Pharmaceuticals Recent Development
    11.9 Mustang Bio
        11.9.1 Mustang Bio Company Details
        11.9.2 Mustang Bio Business Overview
        11.9.3 Mustang Bio Gene Modifying Immunotherapy for Blood Cancer Introduction
        11.9.4 Mustang Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
        11.9.5 Mustang Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of CAR T-cell Therapy
    Table 3. Key Players of TCR T-cell Therapy
    Table 4. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions (2016-2021)
    Table 8. Global Gene Modifying Immunotherapy for Blood Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions (2022-2027)
    Table 10. Gene Modifying Immunotherapy for Blood Cancer Market Trends
    Table 11. Gene Modifying Immunotherapy for Blood Cancer Market Drivers
    Table 12. Gene Modifying Immunotherapy for Blood Cancer Market Challenges
    Table 13. Gene Modifying Immunotherapy for Blood Cancer Market Restraints
    Table 14. Global Gene Modifying Immunotherapy for Blood Cancer Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Players (2016-2021)
    Table 16. Global Top Gene Modifying Immunotherapy for Blood Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Modifying Immunotherapy for Blood Cancer as of 2020)
    Table 17. Ranking of Global Top Gene Modifying Immunotherapy for Blood Cancer Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Gene Modifying Immunotherapy for Blood Cancer Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gene Modifying Immunotherapy for Blood Cancer Product Solution and Service
    Table 21. Date of Enter into Gene Modifying Immunotherapy for Blood Cancer Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Type (2016-2021)
    Table 25. Global Gene Modifying Immunotherapy for Blood Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Application (2016-2021)
    Table 29. Global Gene Modifying Immunotherapy for Blood Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Novartis Company Details
    Table 62. Novartis Business Overview
    Table 63. Novartis Gene Modifying Immunotherapy for Blood Cancer Product
    Table 64. Novartis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021) & (US$ Million)
    Table 65. Novartis Recent Development
    Table 66. Kite Pharma Company Details
    Table 67. Kite Pharma Business Overview
    Table 68. Kite Pharma Gene Modifying Immunotherapy for Blood Cancer Product
    Table 69. Kite Pharma Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021) & (US$ Million)
    Table 70. Kite Pharma Recent Development
    Table 71. Juno Therapeutics Company Details
    Table 72. Juno Therapeutics Business Overview
    Table 73. Juno Therapeutics Gene Modifying Immunotherapy for Blood Cancer Product
    Table 74. Juno Therapeutics Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021) & (US$ Million)
    Table 75. Juno Therapeutics Recent Development
    Table 76. Cellectis Company Details
    Table 77. Cellectis Business Overview
    Table 78. Cellectis Gene Modifying Immunotherapy for Blood Cancer Product
    Table 79. Cellectis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021) & (US$ Million)
    Table 80. Cellectis Recent Development
    Table 81. Ziopharm Oncology Company Details
    Table 82. Ziopharm Oncology Business Overview
    Table 83. Ziopharm Oncology Gene Modifying Immunotherapy for Blood Cancer Product
    Table 84. Ziopharm Oncology Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021) & (US$ Million)
    Table 85. Ziopharm Oncology Recent Development
    Table 86. Celyad Company Details
    Table 87. Celyad Business Overview
    Table 88. Celyad Gene Modifying Immunotherapy for Blood Cancer Product
    Table 89. Celyad Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021) & (US$ Million)
    Table 90. Celyad Recent Development
    Table 91. Bluebird Bio Company Details
    Table 92. Bluebird Bio Business Overview
    Table 93. Bluebird Bio Gene Modifying Immunotherapy for Blood Cancer Product
    Table 94. Bluebird Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021) & (US$ Million)
    Table 95. Bluebird Bio Recent Development
    Table 96. Bellicum Pharmaceuticals Company Details
    Table 97. Bellicum Pharmaceuticals Business Overview
    Table 98. Bellicum Pharmaceuticals Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021) & (US$ Million)
    Table 99. Bellicum Pharmaceuticals Recent Development
    Table 100. Mustang Bio Company Details
    Table 101. Mustang Bio Business Overview
    Table 102. Mustang Bio Gene Modifying Immunotherapy for Blood Cancer Product
    Table 103. Mustang Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021) & (US$ Million)
    Table 104. Mustang Bio Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Type: 2020 VS 2027
    Figure 2. CAR T-cell Therapy Features
    Figure 3. TCR T-cell Therapy Features
    Figure 4. Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Application: 2020 VS 2027
    Figure 5. Acute Lymphocytic Leukemia Case Studies
    Figure 6. Chronic Lymphocytic Leukemia Case Studies
    Figure 7. B Cell Lymphoma Case Studies
    Figure 8. Multiple Myeloma Case Studies
    Figure 9. Other Case Studies
    Figure 10. Gene Modifying Immunotherapy for Blood Cancer Report Years Considered
    Figure 11. Global Gene Modifying Immunotherapy for Blood Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Gene Modifying Immunotherapy for Blood Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions: 2020 VS 2027
    Figure 14. Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions (2022-2027)
    Figure 15. Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Players in 2020
    Figure 16. Global Top Gene Modifying Immunotherapy for Blood Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Modifying Immunotherapy for Blood Cancer as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Gene Modifying Immunotherapy for Blood Cancer Revenue in 2020
    Figure 18. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Type (2016-2021)
    Figure 19. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Type (2022-2027)
    Figure 20. North America Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Gene Modifying Immunotherapy for Blood Cancer Market Share by Type (2016-2027)
    Figure 22. North America Gene Modifying Immunotherapy for Blood Cancer Market Share by Application (2016-2027)
    Figure 23. North America Gene Modifying Immunotherapy for Blood Cancer Market Share by Country (2016-2027)
    Figure 24. United States Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Gene Modifying Immunotherapy for Blood Cancer Market Share by Type (2016-2027)
    Figure 28. Europe Gene Modifying Immunotherapy for Blood Cancer Market Share by Application (2016-2027)
    Figure 29. Europe Gene Modifying Immunotherapy for Blood Cancer Market Share by Country (2016-2027)
    Figure 30. Germany Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Gene Modifying Immunotherapy for Blood Cancer Market Share by Region (2016-2027)
    Figure 40. China Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Gene Modifying Immunotherapy for Blood Cancer Market Share by Type (2016-2027)
    Figure 48. Latin America Gene Modifying Immunotherapy for Blood Cancer Market Share by Application (2016-2027)
    Figure 49. Latin America Gene Modifying Immunotherapy for Blood Cancer Market Share by Country (2016-2027)
    Figure 50. Mexico Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Share by Country (2016-2027)
    Figure 56. Turkey Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Gene Modifying Immunotherapy for Blood Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Novartis Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
    Figure 60. Kite Pharma Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
    Figure 61. Juno Therapeutics Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
    Figure 62. Cellectis Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
    Figure 63. Ziopharm Oncology Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
    Figure 64. Celyad Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
    Figure 65. Bluebird Bio Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
    Figure 66. Bellicum Pharmaceuticals Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
    Figure 67. Mustang Bio Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Kite Pharma
Juno Therapeutics
Cellectis
Ziopharm Oncology
Celyad
Bluebird Bio
Bellicum Pharmaceuticals
Mustang Bio
Frequently Asked Questions
Gene Modifying Immunotherapy for Blood Cancer report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gene Modifying Immunotherapy for Blood Cancer report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gene Modifying Immunotherapy for Blood Cancer report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports